Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

30 Oct 2014 07:00

RNS Number : 6537V
Microgen PLC
30 October 2014
 



microgen

www.microgen.com 30 October 2014

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2014 to the date of this announcement. Microgen released its interim results for the six months ended 30 June 2014 on 21 July 2014.

 

There have been no significant changes since 1 July 2014 in the trading or financial position of Microgen and its balance sheet remains strong. Both of the Group's businesses, Aptitude Software and Financial Systems, continue to perform satisfactorily in line with the Board's current expectations. In line with the Group's seasonal cash flow cycle and the normal variation in timing of customer receipts the Group had cash at 30 September 2014 of £34.7 million (30 June 2014: £37.9 million) and net funds of £17.7 million (30 June 2014: £20.2 million).

 

Investment has continued in the Aptitude Software business with the release of the latest version of the Aptitude technology platform in October. This software version further extends the Aptitude Big Data processing capabilities enabling users to build data-driven applications deploying Aptitude's in-memory, in-database and in-Hadoop processing. In conjunction with this release, the Aptitude Software business has entered into a partnership with Cloudera, the leading distributor of Apache Hadoop. In October, the Aptitude Software business also released the Compact Edition of the Aptitude Accounting Hub, a pre-configured Aptitude-based divisional accounting hub and sub-ledger which complements the Aptitude Revenue Recognition Engine and the Aptitude Allocation Engine released earlier in the year.

 

In August, Aptitude Software signed a contract with a large North American telecommunications company, which is anticipated to generate revenues in excess of $5 million over its expected term. Discussions are also underway with a number of other telecommunications companies related to the potentially very high volume data processing demands associated with the new IFRS 15 (customer contract revenue recognition) accounting requirements.

 

Financial Systems' wealth management product for trust and fund administration, 5Series, continues to be well received in the market with three new contracts entered into since 1 July 2014. In line with the Board's strategy, the Financial Systems' Application Management business continues to decline slowly as some legacy products/solutions approach end of life. A number of add-on acquisitions in the wealth management sector continue to be progressed, although the Board remains prudent and, as always, there can be no certainty that any acquisitions will be completed.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as a business unit under Microgen's stewardship. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMLBPTMBTTBFI
Date   Source Headline
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20215:05 pmRNSGrant of awards under Performance Share Plan
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.